5 Key Takeaways

• 1

  Glaucoma may share molecular similarities with Alzheimer's disease, particularly involving amyloid-β (Aβ) peptides.

• 2

  A study found significantly elevated Aβ₁₋₄₀ and Aβ₁₋₄₂ levels in patients with pseudoexfoliation syndrome and exfoliation glaucoma.

• 3

  Higher Aβ levels correlated with thinner retinal nerve fiber layer thickness, indicating a potential link to retinal ganglion cell loss.

• 4

  The study suggests that Aβ accumulation is independent of age and intraocular pressure, challenging traditional glaucoma narratives.

• 5

  Aβ could serve as a biomarker for glaucoma progression and may inform future therapeutic strategies alongside pressure-lowering treatments.